The Gale readResearch

Belly Fat and Worse Menopause Symptoms: One Snapshot, 1,150 Women

A cross-sectional analysis of 1,150 women in the SWAN cohort found that those whose waist measured at least half their height reported more menopausal symptoms, more severely, and a slightly denser web of links between them — all of it measured at a single visit, with nobody followed forward.

By Gale Staff · November 11, 2026 · Menopause

Not reviewed by a clinician.

The short answer

Women whose waist measured at least half their height did report more menopausal symptoms, and more severe ones, than women below that mark, which is the direction the lifestyle coverage reported. The study's own number for the difference is small: of the 78 possible links between the symptoms it tracked, 46 were present in the abdominal-obesity group against 43 in the other — a density of 0.59 versus 0.55, which the authors themselves call marginally higher. Every measurement came from one visit, so the analysis cannot say whether abdominal fat intensifies symptoms, whether the symptoms shape the weight, or whether something else moves both.

The question the coverage leaves standing at the mirror

A woman stands in her bathroom late at night having read, on her phone, that the fat around her middle may be what is making her hot flashes and her forgetfulness worse. The piece she read moves briskly from that claim to a list of foods and workouts. What it does not tell her is where the claim came from, how large the difference was, or whether anyone in the research lost weight and felt better.

The study underneath that coverage appeared in the journal Menopause in May 2026, six months before the lifestyle article that re-circulated it. Nothing new was found in November. It is also a narrower piece of work than the headline suggests, and the narrowness turns out to be the interesting part.

What the study actually did

Wang and colleagues drew on the Study of Women's Health Across the Nation, known as SWAN, and analysed 1,150 women from the study's sixth visit. The analysis is cross-sectional: the body measurements and the symptom reports come from that same single visit, so there is no before and after anywhere in it.

Abdominal obesity was defined with a tape measure rather than a scan — a waist-to-height ratio of 0.5 or more, meaning a waist at least half the woman's height. That is the whole of the exposure. The published abstract does not say how many of the 1,150 women fell on each side of that line, nor what ages they were.

Rather than asking only whether one group had more of any single symptom, the authors built what the field calls a symptom network. Each symptom is a point, and a line is drawn between two symptoms when they rise and fall together across the women in that group. The measure they lead with is density: the share of all possible lines that are actually present. Across the symptoms they tracked there were 78 possible lines.

What it found

In the abdominal-obesity group, 46 of those 78 links were present, a density of 0.59. In the group below the cut point, 43 were present, a density of 0.55. The authors call that difference marginal, and the arithmetic agrees with them: it is three links out of seventy-eight.

The more substantial result is not the density but the wiring. A network comparison test found the two structures significantly different, while the networks' overall strength stayed comparable — roughly the same total amount of connection, arranged around different symptoms. In the abdominal-obesity group the most connected symptoms were forgetfulness, irritability and night sweats. In the other group they were night sweats, palpitations and depression.

On the simpler question the headline was built from, the authors report that women with abdominal obesity showed both a higher prevalence and a greater severity of several symptoms, and they read the structural difference as possibly reflecting different patterns of symptom interaction or different underlying biology. They suggest the waist-to-height ratio might help identify women who would benefit from treating a cluster of symptoms rather than one complaint at a time.

What the numbers in circulation leave out

The abstract is as far as this account can honestly go, because the full paper sits behind a subscription, and the abstract carries no magnitude for the claim the coverage leads with. The phrase is a "higher prevalence and greater severity of several symptoms", and it arrives without a percentage, a score or a mean beside it, and without the number of women on either side of the 0.5 line. From that, a reader cannot tell whether the difference is the kind a woman would notice in her own week.

The abstract also reports no p-value, confidence interval or test statistic for the structural difference it calls significant, and it names no questionnaire, so which symptoms were on the list and how their severity was scored cannot be checked from it. It states no limitations of its own, which is its own kind of information: the cross-sectional design is named in the methods and left to speak for itself.

Why it is still worth attention

Two things survive the caveats. The first is the measure: a waist-to-height ratio needs no scan, no blood draw and no appointment, which is unusual for a variable that turns up in a journal at all. The second is the shape of the finding. That symptom clusters may differ between women whose bodies differ is a different proposition from belly fat causing hot flashes, and a more useful one, because it points at why two women in the same month of the transition can describe such different experiences.

What the study does not support is the step the coverage takes next. Nobody in this analysis lost abdominal fat, and nobody was followed to see whether their symptoms changed. The claim that reducing abdominal fat relieves hot flashes or brain fog was not tested here, and this design could not have tested it. Clinicians weighing the paper have a hypothesis about how symptoms travel together, not a lever to pull.

What this study can't tell you

  • Whether abdominal fat makes menopausal symptoms worse. The body measurements and the symptoms were recorded at the same visit, so the direction could run either way — symptoms that wreck sleep and curtail activity can also change where weight sits.
  • How big the symptom difference was. The abstract reports a higher prevalence and greater severity of several symptoms without a single percentage, score or mean to weigh it by.
  • How many of the 1,150 women had a waist-to-height ratio of 0.5 or more. The abstract gives no group sizes, so the density figures cannot be read against the number of women behind them.
  • Whether losing abdominal fat changes anything. No one was treated and no one was followed forward; there is no intervention in this study.
  • How strong the evidence for the structural difference is. The abstract calls the network difference significant but reports no p-value, confidence interval or test statistic for it.
  • Who the finding applies to, and how the symptoms were measured. The abstract states neither the ages nor the ethnic composition of this SWAN subsample, and names no symptom questionnaire.

The Gale read

This paper is a hypothesis about shape, not a finding about cause, and the lifestyle coverage inverted that. Its most defensible result is also its least quotable: two groups of women carried about the same total amount of symptom interconnection arranged around different symptoms, with forgetfulness and irritability central among those with larger waists, and palpitations and depression central among those without. That is worth a researcher's next study and a clinician's curiosity. It is not worth a diet. A density of 0.59 against 0.55, measured at one visit, with no group sizes and no effect sizes in the abstract, cannot carry the weight of advice, and the paper never claims it can — the recommendation it does make, that a tape measure might flag women whose symptoms cluster so the cluster can be treated rather than one complaint at a time, is modest, testable and still untested. The honest position is that the waist is interesting here as a marker, and that anyone selling it as a cause is selling something the evidence has not yet earned.

Common questions

does belly fat make hot flashes worse

This study cannot settle that. It measured waists and symptoms on the same day in 1,150 SWAN participants, and night sweats were among the most connected symptoms in both groups — those with a waist-to-height ratio of 0.5 or more and those below it. Women above that cut point reported a higher prevalence and greater severity of several symptoms, but with no one followed over time, the association is equally consistent with symptoms influencing weight, or with a third factor moving both.

does abdominal fat affect menopause symptoms

In this analysis the two travelled together. Women with a waist at least half their height reported more symptoms and more severe ones, and their symptom network was slightly denser — 46 of 78 possible links against 43, or 0.59 against 0.55. The networks also differed in structure while their overall strength stayed comparable, which the authors read as symptoms interacting in a different pattern rather than simply being worse across the board.

why are my menopause symptoms more severe

This paper offers no answer for any individual woman, and it does not try to. It compared two groups defined by one body measurement and found their symptom patterns differently arranged: forgetfulness, irritability and night sweats sat at the centre of the network in women with abdominal obesity, while night sweats, palpitations and depression sat at the centre in women without it. Severity has many contributors the study did not measure, including sleep, medication, menopausal stage and mood.

waist to height ratio menopause symptoms

The waist-to-height ratio is the measure this study used to define abdominal obesity: a waist of at least half the person's height, a ratio of 0.5 or more. Its appeal is practicality — a tape measure, no scan or blood draw. The authors suggest it could help identify women whose symptoms cluster tightly enough to be worth treating as a cluster, though that suggestion has not been tested in a trial.

Sources

  1. 1.Wang D, Wang F, Zheng J, Chen X, Lei Y, Su J. Menopausal symptom network differences between women with and without waist-to-height ratio-defined abdominal obesity. Menopause (New York, N.Y.). 2026 May; published online 5 May 2026. doi:10.1097/GME.0000000000002794. link
  2. 2.Europe PMC record read for this piece: PMID 42084915 (Wang D, et al., Menopause (New York, N.Y.), 2026). The full text is subscription-only and not in PubMed Central, so this piece is written from the methods, results and conclusions as reported in that abstract, and says where the abstract is silent. link

Read the study →

2 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

More from Gale Staff

The Latest Health Research →

Published November 11, 2026 · Gale Staff

All Gale Staff analyses →